CervoMed Inc. Increase (Decrease) in Deferred Charges
CervoMed Inc. (CRVO) reported Increase (Decrease) in Deferred Charges of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2026-08-07
- CervoMed Inc. increase (decrease) in deferred charges for the quarter ending 2025-12-31 was $41.25K.
- CervoMed Inc. increase (decrease) in deferred charges for the quarter ending 2025-09-30 was $105.98K.
- CervoMed Inc. increase (decrease) in deferred charges for the quarter ending 2024-12-31 was $0.00.
- CervoMed Inc. increase (decrease) in deferred charges for the quarter ending 2024-09-30 was $0.00.
- CervoMed Inc. increase (decrease) in deferred charges for fiscal 2025 was $310.58K.
- CervoMed Inc. increase (decrease) in deferred charges for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $41.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $147.23K derived: sum of 2 quarters · filed 2026-03-13 | $310.58K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $105.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $269.33K 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $163.35K 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-13 | $0.00 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |||
| 2023-06-30 | $421.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.06M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $638.02K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |